Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.010
+0.190 (10.44%)
May 12, 2025, 3:54 PM - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $277.95 million as of May 12, 2025. Its market cap has increased by 36.50% in one year.
Market Cap
277.95M
Enterprise Value
145.42M
1-Year Change
36.50%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $277.95M, a decrease of -36.15%. That is a compound annual growth rate of -10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 251.67M | 26.15% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.48B |
| Johnson & Johnson | 371.83B |
| UnitedHealth Group | 344.03B |
| AbbVie | 337.65B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.73B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |